Advice You
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Ezine Publishing > Double Opt-In Or Single?

Tags

  • somebody
  • doesnt
  • right
  • email address
  • using single
  • email address

  • Links

  • Need Money Tips: Biggest Hindrance Is Using Marketing Methods That Don't Work Online
  • Stop Smoking Program
  • Investing-Are You Ready?
  • Advice You - Double Opt-In Or Single?

    You have gotten to the point where you are ready to accept subscribers to your Ezine. But now comes the decision. Do you want your subscription
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    service to be single of double opt-in? Well, to answer that question, we first have to explain the difference between the two methods. Then we c
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    an list the pros and cons of each.

    Single opt-in works as follows. The potential subscriber sees your ad for your Ezine and the sign up link an
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    simply puts his email in the form, clicks send and he is now a subscriber. He doesn't have to do anything else. You'll have his information del
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ivered to your system and he will be added to your subscriber base. When your first Ezine goes out, he will be getting a copy of it.

    Double opt
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    -in works as follows. The potential subscriber also sees your ad for your Ezine, just like in the example about, except there is one difference.
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    After he submits his email address and clicks send, a message will come up telling him that he will be receiving an email that he will have to r
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    eply to in some form, usually by clicking a link in the email. After he does this, THEN he is added to your subscriber base.

    Okay, so what's th
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    e difference? Why make somebody go through the extra step? Isn't single opt-in good enough? This is where we get to the pros and cons of each me
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    hod. You can decide on your own which is best for you.

    With single opt-in, after the subscriber submits his info, he is in. This makes it easie
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    r for him to become a subscriber. The extra step may be too much of a bother for him and he will never click on your link, thus he will never be
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    come a subscriber. Thus somebody who would have been, is not. You have lost a potential subscriber. Another positive of single opt-in is that th
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    re is less programming involved for the system as there are fewer steps involved. That's the positive side of using single opt-in over double op
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    t-in. Naturally, single opt-ins positive side is double opt-ins negative side.

    But there is a downside to using single opt-in. With single opt-
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    in, a subscriber could enter any email address and it won't matter. Why? Because he doesn't have to confirm it. So if your Ezine requires that i
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    be emailed to him, he will never get it. While this may seem silly, some people will do this just to be able to download the freebies before ge
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    tting their first email. This way they get the freebie and don't have to be bothered with your emails. By having double opt-in it forces them to
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    give a valid address or they don't get any of the benefits. While this may decrease the number of subscribers you get, it will increase the num
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    er of serious subscribers that you get. And 100 serious subscribers are much better than 10,000 not so serious subscribers.

    There are those who
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    will argue in favor of each and that's fine. There really is no right or wrong answer here. It all comes down to what you feel it right for YOU


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.adviceyou.org.ua/article/63342/adviceyou-Double-OptIn-Or-Single.html">Double Opt-In Or Single?</a>

    BB link (for phorums):
    [url=http://www.adviceyou.org.ua/article/63342/adviceyou-Double-OptIn-Or-Single.html]Double Opt-In Or Single?[/url]

    Related Articles:

    ROI Re-examined

    Critical Business Plan Disciplines and Resources

    Hurricanes and Audio Internet Streaming

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    torby foliowe Hotele warszawa Święta Amazing Atomic Activity Biuro Rachunkowe Kraków